alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › amyloid-lowering

amyloid-lowering

3 studies tagged amyloid-lowering, dated 2015-07-15 to 2025-07-21. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Amyloid-lowering immunotherapies for Alzheimer disease: current status and future directions 2025-07-21
  2. Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases 2025-01-24
  3. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs 2015-07-15

Studies

3 studies carry this tag.

Date range

2015 to 2025

Top journals

  • Journal of neurology 1
  • Nature reviews. Neurology 1
  • Neural plasticity 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Amyloid-lowering immunotherapies for Alzheimer disease: current status and future directions

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Nature reviews. Neurology 2025-07-21 Treatments

    The treatment of Alzheimer disease (AD) has crossed a pivotal threshold, marked by the landmark approvals of the first-ever disease-modifying therapies.

  2. Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Journal of neurology 2025-01-24 Treatments

    These cases suggest that recurrent ARIA-E do not inevitably lead to accelerated progression, instead, may relate to possible long-term benefits.

  3. Neural Stem Cell Transplant-Induced Effect on Neurogenesis and Cognition in Alzheimer Tg2576 Mice Is Inhibited by Concomitant Treatment with Amyloid-Lowering or Cholinergic α7 Nicotinic Receptor Drugs

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Neural plasticity 2015-07-15 Treatments

    Stimulating regeneration in the brain has the potential to rescue neuronal networks and counteract progressive pathological changes in Alzheimer's disease (AD).

All topic tags with their study counts